Drug maker Indivior joins London Stock Exchange exodus
Indivior to delist on 25 July Move aligns with US market focus Shares down 35% over one year Global pharmaceutical firm Indivior (INDV) is to become the latest company to delist from the London Stock Exchange (LSE) in favour of the US market in the latest blow to Britain's embattled bourse. Headquartered across the pond in Richmond, Virginia, the opioid addiction treatment specialist will...